Aura Biosciences Receives FDA Clearance of Investigational New Drug Application for Light-activated AU-011 for the Treatment of Ocular Melanoma Read more
Strata Oncology Announces Collaboration with Epizyme to Support Tazemetostat Clinical Development Read more
Portola Pharmaceuticals Signs $150 Million Royalty Agreement with HealthCare Royalty Partners for Development and Commercialization of Andexanet Alfa Read more
Cocoon Biotech Announces Partnership with Camargo Pharmaceutical Services for Development Programs Read more
Arven selects GE Healthcare’s manufacturing platform to expand production capacity at Turkish facility Read more